Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > It's time for a takout

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Jul 26, 2023 9:18am

112 Views

Post# 35557404

RE:RE:RE:RE:RE:RE:RE:RE:RE:It's time for a takout

My comment was in reposnse to the fact Paul destroyed the company and should be fired immediatly. This company is damaged behond repair, fire evryone ecept the saleforce and SELL the whole company instead of giving away 25%+ of it to get the company to next year....

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management